LoFi-DeFi Making History with a Massive Fair Launch
CHARLOTTE, NC / ACCESSWIRE / August 13, 2021 / The last two weeks saw decentralized…
CHARLOTTE, NC / ACCESSWIRE / August 13, 2021 / The last two weeks saw decentralized…
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / August 13, 2021 / Achieve Life Sciences,…
The career corporate executive recounts the many ups and downs of his professional life, and…
INTERIM FINANCIAL RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2021 LONDON, UK / ACCESSWIRE…
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus…
HALIFAX, NS / ACCESSWIRE / August 12, 2021 / Meta Materials Inc. (the “Company” or…
DURANGO, CO / ACCESSWIRE / August 12, 2021 / Rocky Mountain Chocolate Factory, Inc. (NASDAQ:RMCF)…
Senior management’s experience in transformation and project management will support companies in the Middle East…
Orange County Bancorp, Inc. Announces Record Second Quarter 2021 Results Net Income for Q2 2021…
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES…
Message from the CEO As is well known, IBT is conducting a large phase III…
SEATTLE and CAMBRIDGE, United Kingdom, Aug. 12, 2021 (GLOBE NEWSWIRE) — Eliem Therapeutics, Inc. (NASDAQ:…
Initiated preclinical animal studies for MN-166 as a treatment for chlorine gas-induced induced lung disease…
BRIDGEWATER, N.J., Aug. 12, 2021 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or…
The exclusively licensed platform has potential application for any tumor target Preclinical development to continue…
SAN DIEGO, Aug. 12, 2021 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology…
Clinical trial programs for vidutolimod (CMP-001) in melanoma and head and neck cancer indications ongoing…
AUSTIN, Texas, Aug. 12, 2021 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or…
PALISADE Phase 3 Program to evaluate PH94B for rapid-onset acute treatment of anxiety in adults…
Reported Promising Updated Clinical Data in Ongoing Clinical Trials of Galinpepimut-S (GPS) in Combination with…